Attached files
| file | filename |
|---|---|
| 10-Q - INTERLEUKIN GENETICS INC | v193469_10q.htm |
| EX-31.1 - INTERLEUKIN GENETICS INC | v193469_ex31-1.htm |
| EX-10.1 - INTERLEUKIN GENETICS INC | v193469_ex10-1.htm |
| EX-10.2 - INTERLEUKIN GENETICS INC | v193469_ex10-2.htm |
| EX-31.2 - INTERLEUKIN GENETICS INC | v193469_ex31-2.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS
(A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED
STATES CODE)
Pursuant to section 906 of the
Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350,
chapter 63 of title 18 United States Code), each of the undersigned officers of
Interleukin Genetics, Inc., a Delaware corporation (the “Company”),
does hereby certify, to such officer’s knowledge, that:
The Quarterly Report of
Form 10-Q for the quarter ended June 30, 2010 (the “Form 10-Q”) of the
Company fully complies with the requirements of Section 13 (a) or 15
(d) of the Securities Exchange Act of 1934, and the information contained
in the Form 10-Q fairly presents, in all material respects, the financial
condition and results of operations of the Company.
|
Date:
August 12, 2010
|
/s/
Lewis H. Bender
|
|
Lewis
H. Bender
Chief
Executive Officer
|
|
|
Date:
August 12, 2010
|
/s/
Eliot M. Lurier
|
|
Eliot
M. Lurier
Chief
Financial Officer
|